Ubiquinone, ubiquinol, 4-hydroxybenzoic acid… What 'coenzyme Q10' should we care about in multiple system atrophy?

Related Experiment Videos

Yaroslau Compta¹, Esteban Muñoz², Maria J Martí²

¹Parkinson's Disease and Movement Disorders Unit, Neurology Service, ICN, Hospital Clínic, IDIBAPS, CIBERNED, Barcelona, Catalonia, Spain; Physiology Unit, Department of Biomedicine, Institut de Neurociències, University of Barcelona, Barcelona, Catalonia, Spain.

Parkinsonism & Related Disorders

|February 14, 2018

Abstract

No abstract available in PubMed .

Keywords:

4-Hydroxibenzoic acid Biomarker Coenzyme Q10 Multiple system atrophy Therapeutic target

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Brain : a journal of neurology·2026

Regional wasteosome accumulation across neurodegenerative diseases points to a shared underlying mechanism potentially related to glymphatic insufficiency.

Acta neuropathologica communications·2026

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

NPJ Parkinson's disease·2026

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026

Age-stratified associations between severe mental illness, dementia, and ischemic stroke: findings from the PADRIS-PRESTO cohort.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026

Unraveling the genetic architecture of non-Huntington chorea: a biobank-scale study of rare variants and repeat expansions.

NPJ genomic medicine·2026

See all related articles